XDemics
Monrovia, California, United States · Biotechnology · 9 employees
XDemics is a Caltech spinout biotechnology company improving how cells are grown by solving a key bottleneck in cell culture: efficient oxygen transfer during cell growth. Powered by its high-density cell respiration (HDCR) technology, XDemics enables mammalian cells to grow at 20- to 100-fold higher densities across lab and industrial settings, helping researchers and manufacturers produce more v
Funding history
- Funding Round — $7.4M — Feb 2026
- Funding Round — $5.5M — Dec 2024
- Series seed — $1.9M — Sep 2024
- Funding Round — $1.9M — Jul 2024
- Series seed — $1.9M — Jun 2024
Recent signals
- Feb 06, 2026: Raised $7.4M
- Dec 05, 2024: Raised $5.5M
- Sep 13, 2024: Raised $1.9M in Series seed
- Jul 23, 2024: Raised $1.9M
- Jun 12, 2024: Raised $1.9M in Series seed
See plans & pricing → Track XDemics’s funding, hiring, and signals — with verified contacts — on Fundz.